{"nct_id":"NCT02738775","title":"Phase IIa Study of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis","status":"COMPLETED","status_verified_date":"2021-06","start_date":"2016-05-27","start_date_type":"ACTUAL","primary_completion_date":"2017-09-27","primary_completion_date_type":"ACTUAL","completion_date":"2018-08-13","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TGTX"]}